ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,155, issued on Aug. 26, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Thienopyridinone compounds" was invented by Luoheng Qin (Shanghai), Zhao-Kui Wan (Shanghai), Haibing Guo (Shanghai) and Qian Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to new thienopyridinone compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and to their use in the treatment of diseases, e.g. cancer."

The patent was filed on Dec. 25, 2019, under Application No. 17/417,98...